Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40009753
Localisation
Japan
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
25/01/2024
Statut
Classification
1.5°C
Année cible
FY2030
Nippon Shinyaku commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from a FY2020 base year. Nippon Shinyaku also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 25% within the same timeframe.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
JP3717600005
Source : Science Based Targets initiative | Données publiques